Actavis to spend $66 billion on Allergan
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
Nov 17, 2014
0
0
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
Nov 17, 2014
0
0
Shares of Elan Corp PLC jumped Friday after the Irish drugmaker said it will explore a possible sale of the company while its board continues to fend off a hostile takeover bid from Royalty Pharma.
Jun 14, 2013
0
0
Switzerland will close its schools in a bid to halt the spread of the new coronavirus, the government said Friday, adding that it would provide billions in aid to hard-hit businesses.
Mar 13, 2020
0
3
Valeant Pharmaceuticals said Wednesday it has launched a tender offer for Allergan, the maker of Botox, taking its hostile bid directly to shareholders.
Jun 18, 2014
0
0
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...
Jun 4, 2013
0
0
(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.
Mar 4, 2013
0
0
Shareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan.
Jun 17, 2013
0
0
Despite the pandemic, Australia is in the midst of a hugely competitive auction market. Sydney, in particular, is experiencing dizzying auction clearance rates and the Reserve Bank's decision this week to keep interest rates ...
Mar 4, 2021
0
0